Skip to main content
. 2022 Oct 27;14(21):5292. doi: 10.3390/cancers14215292

Figure 1.

Figure 1

Comparison of mALF, AFP, and mALBI for prediction of recurrence-free survival (RFS) and overall survival (OS). (A) RFS in patients with mALF scores of 0, 1, and 2 points. (B) OS in patients with mALF scores of 0, 1, and 2 points. (C) RFS in patients with AFP <100 and ≥100 ng/mL. (D) OS in patients with AFP <100 and ≥100 ng/mL. (E) RFS in patients with mALBI 1 or 2A and 2B or 3. (F) OS in patients with mALBI 1 or 2A and 2B or 3.